US3670074A - Sunscreen formulation containing triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid - Google Patents
Sunscreen formulation containing triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid Download PDFInfo
- Publication number
- US3670074A US3670074A US108961A US3670074DA US3670074A US 3670074 A US3670074 A US 3670074A US 108961 A US108961 A US 108961A US 3670074D A US3670074D A US 3670074DA US 3670074 A US3670074 A US 3670074A
- Authority
- US
- United States
- Prior art keywords
- percent
- sulfonic acid
- formulation
- weight
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 48
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 29
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 title claims abstract description 27
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title claims description 85
- 238000009472 formulation Methods 0.000 title claims description 66
- 239000004480 active ingredient Substances 0.000 claims description 27
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 26
- 229960004418 trolamine Drugs 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 18
- 229920002545 silicone oil Polymers 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 11
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 239000004264 Petrolatum Substances 0.000 claims description 10
- 239000006210 lotion Substances 0.000 claims description 10
- 229940066842 petrolatum Drugs 0.000 claims description 10
- 235000019271 petrolatum Nutrition 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 9
- 229960000541 cetyl alcohol Drugs 0.000 claims description 9
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims description 9
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 9
- 239000000600 sorbitol Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 8
- 239000011928 denatured alcohol Substances 0.000 claims description 6
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- 239000002480 mineral oil Substances 0.000 claims description 6
- 235000010446 mineral oil Nutrition 0.000 claims description 6
- 235000013871 bee wax Nutrition 0.000 claims description 5
- 239000012166 beeswax Substances 0.000 claims description 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 229960002216 methylparaben Drugs 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 229960003415 propylparaben Drugs 0.000 claims description 4
- 239000012185 ceresin wax Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 abstract description 9
- 239000003981 vehicle Substances 0.000 description 30
- 150000008366 benzophenones Chemical class 0.000 description 16
- 239000000499 gel Substances 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 12
- 235000010356 sorbitol Nutrition 0.000 description 12
- 238000013019 agitation Methods 0.000 description 10
- 239000003995 emulsifying agent Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 7
- FBPFZTCFMRRESA-NQAPHZHOSA-N Sorbitol Chemical compound OCC(O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-NQAPHZHOSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- -1 fatty acid esters Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- AMGNHZVUZWILSB-UHFFFAOYSA-N 1,2-bis(2-chloroethylsulfanyl)ethane Chemical compound ClCCSCCSCCCl AMGNHZVUZWILSB-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- HMKKFLSUPRUBOO-IUPFWZBJSA-N 3,4-dihydroxy-5-[3,4,5-tris[[(z)-octadec-9-enoyl]oxy]benzoyl]oxybenzoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C(OC(=O)CCCCCCC\C=C/CCCCCCCC)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(O)=O)O)=C1 HMKKFLSUPRUBOO-IUPFWZBJSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 208000016311 Freckling Diseases 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 1
- 229920001214 Polysorbate 60 Chemical class 0.000 description 1
- 241000097929 Porphyria Species 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000159 acid neutralizing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940074323 antara Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940003587 aquaphor Drugs 0.000 description 1
- OYJQAICEYJBQGK-UHFFFAOYSA-N azanium ethanol fluoride Chemical compound [NH4+].[F-].CCO OYJQAICEYJBQGK-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical class C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid ester group Chemical class C(CCCCCCCCCCC)(=O)O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000000816 ethylene group Chemical class [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- ZHALDANPYXAMJF-UHFFFAOYSA-N octadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCCC([O-])=O ZHALDANPYXAMJF-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical class OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000002730 suntanning agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229940029614 triethanolamine stearate Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- MTZBBNMLMNBNJL-UHFFFAOYSA-N xipamide Chemical compound CC1=CC=CC(C)=C1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1O MTZBBNMLMNBNJL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
Definitions
- ABSTRACT An active sunscreen ingredient comprised of 2-hydroxy-4- methoxy-benzophenone-S-suifonic acid, neutralized with triethanoiamine, and formulated with various compatible vehicles to produce efiective sunscreens for human use.
- the present invention relates to ultraviolet absorbers and more particularly to sunscreen formulations for protection of human skin from solar radiation.
- agent which produce sensitivity are the sulfonamides, tranquilizers of the phenothiazine type, the sulfonylurea oral antidiabetic agents and the antihypertensive diuretic agents.
- benzophenone derivatives are utilized as sunscreen agents in protecting natural and man-made materials, such as textile goods, dyes and coloring agents, various resins, coating and film materials, and miscellaneous chemical compositions against the action of sunlight, these benzophenones are unsuitable for human skin for a number of reasons, including that they are highly irritating and do not lend themselves to acceptable formulations for human use.
- the invention provides a sunscreen formulation containing an active ingredient for the protection of human skin from solar radiation comprised of a triethanolamine neutralized 2- hydroxy-4-methoxy benzophenone-S-sulfonic acid, in a compatible vehicle, which may include an emulsifier, such a glycerol monostearate, a wax, such as beeswax, water, an alcoho], such as denatured or cetyl alcohol, thickening agents, preservative agents, perfumes, etc.
- an emulsifier such as a glycerol monostearate
- a wax such as beeswax
- water an alcoho
- thickening agents such as denatured or cetyl alcohol
- preservative agents perfumes, etc.
- the amount of active ingredient within the formulation ranges in amounts from about 0.1 percent to about 30 percent.
- the invention provides a sunscreen agent that prevents and/or substantially minimizes the photochemical degradation and other adverse effects caused by exposure of human skin to sunlight through the absorption of ultraviolet wave lengths.
- the sunscreen agents of the invention absorb or screen radiation wave lengths responsible for erythema on human skin, minimizes the aging effects of solar radiation on humans and inhibits freckling or irregular pigmentation from such radiation.
- the sunscreen agents of the invention are readily incorporated into various types of vehicles for cosmetic materials, such as make-up bases, face powders, after-shave lotions, etc. for use by individuals who freckle, are afflicted with chloasma, or prefer their natural color, as well as by others.
- the sunscreen agents of the invention also tend to decrease sunlight accelerated aging and sunlight induced carcinogenesis on exposed human skin which has been coated with a formulation of said agents.
- the sunscreen agents of the invention comprise Z-hydroxy- 4-methoxy-benzophenone-5-sulfonic acid neutralized with a neutralization agent having properties of triethanolamine and are formulated into any desired carrier, vehicle, emulsion, cream, lotion, ointment, solution, suspension, gel, aerosol or in any other form suitable for human usage.
- the active sunscreen agent of the invention is 2-hydroxy-4-methoxy-benzophenone-5sulfonic acid neutralized with triethanolamine.
- the amount of active sunscreen agent of the invention in a given formulation ranges from about 0. 1 percent to about 30 percent or more as desired.
- the emulsions, gels, vehicles, etc. utilized in preparing sunscreen formulations containing the active sunscreening agents of the invention contain any one or combinations of; cetyl alcohol, stearyl alcohol, stearic or lauric acids and all other fatty acids and alcohols generally used in cosmetic and like materials emulsions or other formulations intended for human use; various waxes such as beeswax, microcrystalline wax, spermaceti, etc., and all other waxes generally used in cosmetic and like material emulsions or other formulations intended for human use; various petroleum materials, such as petrolatum, liquid petrolatum, mineral oil, silicone oil, etc.
- oils, fats, and the like materials generally used in cosmetic and like material emulsions or other formulations intended for human use fatty acid esters, such as isopropyl myristate and similar esters of fatty acids having a composition generally ranging from about C to about C various silicone derivatives, polyvinyl pyrrolidone methyl or propyl paraben, C to C glycols, various stearates, and other materials whether similar or otherwise that are generally used or considered suitable for use in cosmetic and like material emulsions or other formulations intended for human use.
- the vehicle materials, emulsifiers, combination of emulsifiers, and other like material compatible with the active sunscreen ingredients or agents of the invention are also selected from various anionic surfactants, including amine soaps of fatty acids such as characterized by triethanolamine stearate; cationic surfactants, such as characterized by monoethanol ammonium fluoride; amphoteric surfactants such as characterized by N-fatty B-amino-propionate (RNI-I CH -CH COOH); and nonionic surfactants such as characterized by sorbitan derivatives of C to C fatty acids, polyoxyethylene sorbitan derivatives of C to C fatty acids, polyoxyethylene esters of C to C fatty acids, glyceryl stearates, fatty acid polyisopropylene complexes; and ethylenes oxide fatty alcohol lanolin complexes.
- anionic surfactants including amine soaps of fatty acids such as characterized by triethanolamine stearate; cationic surfact
- compatible materials, vehicles, carriers, gels and like materials include perfumes, clays, preservative agents, etc. and are all utilizable with the active sunscreen agents of the invention in formulating suitable gels, emulsions, either of the water-in-oil type or the oil-in-water type, aerosols, etc. or other forms suitable for application to humans.
- a 5 percent concentration of PABA (para-amino-benzoic-acid) and a 5 percent concentration of triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid in a compatible vehicle each provided protection for about 20 to 25 minutes.
- the active sunscreen agents of the invention generally comprise suitably neutralized 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid, and similar benzophenone derivatives having the formula:
- A is selected from a neutralizing agent having properties characterized by triethanolamine.
- the active sunscreen agents of the invention are utilized in a variety of formulations and are present therein in amounts ranging from about 0.1 percent to about 30 percent by weight.
- sunscreen agents of the invention in various formulations, bases, carriers, emulsifiers and other compatible vehicles, the following examples are set forth.
- UVINUL MS40 A 2-hydroxy-4-methoxy benzophenone-S-sulfonic acid is available from Antara Chemical, New York, New York under the registered tradename UVINUL MS40 and U- VINUL-40-20 percent Aqueous Solution.
- UVINUL MS-40 is a free flowing powder at 25 C., light-cream in color and has a molecular weigh of 309 and a pH 2 for a l percent aqueous solution, with a solubility of about 5 g/lOO mls of water at 25 C. after 15 minutes of agitation.
- U- VINUL MS-40-20% Aqueous Solution is the same material in an aqueous solution at the concentration indicated.
- the powder is first dissolved in water and then combined with a suitable neutralizing agent and a particular vehicle.
- EXAMPLE I A typical embodiment of an oil-in-water emulsion formulation utilizing UVINUL MS-40-20% Aqueous Solution, (referred to as Benzophenone Derivative) in its neutralized form, an the active ingredient is as follows, with all parts being by weight unless otherwise noted.
- Emulsion Vehicle ARLACEL 165 Glyceryl Monostearate
- Cetyl Alcohol 2% Isopropyl Palmitate 2% Dimethyl Silicone Oil
- Light Liquid Petrolatum 2% Polyvinyl Pyrrolidone 0.5%
- ARLACEL is a tradename for a glyceryl monostearate containing emulsifier available from Atlas Chemical Industries, Inc., of Wilmington, Delaware and Sorbo 70% is a tradename for a sorbitol containing emollient having 70 percent solids also available from Atlas Chemical Industries, Inc.
- An alternative emulsifier usable in place of "ARLACEL 165" is Prornulgen," a tradename for an emulsifier available from Robinson Wagner Company, Inc., of Mamaroneck, New York.
- the above embodiment of a particular formulation can be varied by adjusting the amount of active ingredient so as to vary between about O.l percent to about 30 percent and by adjusting and/or omitting certain ingredients of the vehicle.
- the amount of glycerol monostearate can vary between about 3 percent to 5 percent, the silicone oil, i.e.
- dimethyl silicone oil, and/or the petrolatum can be replaced by mineral oil and the amount varied between about 1 percent to 15 percent, the amount of sorbitol varied between about 3 percent to 30 percent or partially replaced by a glycol, the amounts of isopropyl palmitate, and polyvinyl pyrrolidone may also be varied and/or replaced with other comparable material and even omitted as exemplified in further embodiments set forth hereinafter.
- minor amounts perfumes and/or preservative agents are added as desired.
- the invention is not limited to the specific proprietary items set forth in the examples but includes all emulsifiers, emollients, carriers, vehicles, preservatives, perfumes and other materials generally found in cosmetic materials, sun protective formulations, etc., suitable for use on human skin.
- the formulation of the above embodiment of an oil-inwater emulsion is carried out by placing the appropriate amounts of ARLACEL 165, cetyl alcohol, dimethyl silicone oil and light liquid petroletum in a suitable steam-jacketed kettle or the like and subjecting the mixture to slow agitation and heating conditions to about 70 C. so as to form a first solution.
- the remaining ingredients of the emulsion vehicle i.e. all of the remainder ingredients except the active ingredient, are placed in another suitable container and slowly agitated and heated up to about 75 C. to form a second solution.
- the two solutions are then combined with continuous and vigorous agitation by adding the second solution to the first solution.
- the sulfonated 2-hydroxy-4-methoxybenzophenone derivative is neutralized with a sufficient amount of an amine having properties characterized by triethanolamine and added to the combined solutions at about 35 C. with agitation sufficient to achieve a generally homogeneous or uniform mixture.
- Perfumes or preservative agents such as methyl and/or propyl paraben or the like can readily be included in the formulation in an appropriate amount, if desired.
- Active Ingredient Amounts Benzophenone Derivative 3% to Triethanolamine (U.S.P.) 0.5.
- Emulsion Vehicle ARLACEL I86 (Monoand di- Glycerides of fat forming fatty acids) 3% SORBO” (70% aqueous solution of d-sorbitol) 27% Ceresin Wax 1% Beeswax 1% Mineral Oil 1 1% Water to 100% ARLACEL 186" and SORBO are tradenames of an emulsifier and an emollient respectively, available from the Atlas Chemical Industries, Inc. referred to earlier.
- the formulation of the above embodiments is carried out by preparing an intermediate gel comprised of adding a small amount of SORBO and ARLACEL 186 and subjecting the mixture of mechanical agitation to form a relatively thick slurry. Thereafter, the remainder of SORBO ingredient is added with continuous agitation and then the benzophenone derivative, in its neutralized form, the waxes and the mineral oil are added to the intermediate gel and slowly agitated and heat up to about 70 C. The water is then heated to about 72 C. and added to the gel mixture with continuous agitation. The agitation is continued until the resultant formulation cools to room temperature. In order to provide maximum smoothness and stability, the formulation is subjected to homogenization or milling procedures.
- EXAMPLE III A typical embodiment of a liquid solvent formulation utilizing 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in its neutralized form as the active ingredient is as follows, with all parts being by weight.
- the formulation of the above embodiment is carried out by combining the active ingredient with the solvent vehicle under vigorous agitation and gentle heat conditions for a period of time sufficient to produce a relatively clear solution. Perfumes or the like are also added as desired.
- EXAMPLE IV A typical embodiment of a gel (clear or opaque) formulation utilizing 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in its neutralized form as the active ingredient is as follows, with all parts being by weight.
- Carbopol 940 is a tradename for an emulsifier material comprised of a vinyl polymer with active carboxyl groups available from B. F. Goodrich Company (The Merck Index, 8th Edision, 1968, Page 201
- the formulation of the above gel embodiment is carried out by combining the gel vehicle with the benzophenone derivative under agitation and heat conditions sufficient to produce a clear gel solution. Thereafter the triethanolamine is slowly stirred into the solution until a gel forms. The formed gel is suitable for use on human skins.
- the benzophenone derivative is carried into an appropriate vehicle by dissolving or suspending it in water, alcohol, glycerine, propylene glycol or any other suitable solvent or combination of solvents generally recognized as safe or compatible to human skin.
- suitable suspension agents such as organic clays, pectin, synthetic resins, etc. are also utilizable in appropriate proportions in the formulations of the invention, additionally, tragacanth, agar-agar or similarly characterized thickening agents are also suitable for use in the formulations of the invention.
- the invention provides active sunscreen agents or ingredients compatible with a wide variety of vehicles or carriers in sunscreen formulations wherein the active ingredient is present in amounts ranging from about 0.1 percent to about 30 percent.
- the preferred active ingredient of the invention is 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid neutralized with triethanolamine, although other suitably neutralized 2-hydroxy-4-methoxy-benzophenone-5- sulfonic acid derivatives are also utilizable.
- a sunscreen formulation in the form of an emulsified 10- tion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid in amounts ranging from 0.1 percent to 30 percent of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 3 percent to 5 percent glycerol monostearate, 1 percent to 3 percent cetyl alcohol, 1 percent to 3 percent isopropyl palmitate, 1 percent to 15 percent dimethyl silicone oil, percent to 3 percent light liquid petrolatum, 0.1 percent to 1 percent polyvinyl pyrrolidone, 3 percent to 30 percent sorbitol and up to 100 percent water.
- a sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid in amounts ranging; from 0.l percent to 30 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 3 percent to 5 percent glycerol monostearate, 2 percent cetyl alcohol, 2 percent isopropyl palrnitate, 3 percent dimethyl silicone oil, 2 percent light liquid petrolatum, 0.5 percent polyvinyl pyrrolidone, 7 percent sorbitol and up to 100 percent water.
- a sunscreen formulation in the form of an emulsified 10- tion suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4rnethoxy-benzophenone-S-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 5 percent glycerol monostearate, 2 percent cetyl alcohol, 2 percent isopropyl palmitate, 3 percent dimethyl silicone oil, 2 percent light liquid petrolatum, 0.5
- a sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid in amounts ranging from about 3 percent to 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanol-amine, and a compatible vehicle comprising a mixture of, by weight, 3 percent glycerol monoand di-stearate, 19 percent sorbitol, 1 percent ceresin wax, 1 percent beeswax, ll percent mineral oil and up to 100 percent water.
- a sunscreen formulation in the form of a liquid suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 20 percent denatured alcohol, 3 percent dimethyl silicone oil and up to 100 percent water.
- a sunscreen formulation in the form of a liquid suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4-methoxy-benzophenonc-5-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 30 percent denatured alcohol, 3 percent dirnethyl silicone oil, 0.5 percent glycerol monostearate and up to 100 percent water.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
An active sunscreen ingredient comprised of 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, neutralized with triethanolamine, and formulated with various compatible vehicles to produce effective sunscreens for human use.
Description
United States Patent Doner, deceased [451 June 13, 1972 SUNSCREEN FORMULATION CONTAINING TRIETHANOLAMINE NEUTRALIZED 2-HYDROXY-4- METHOXY-BENZOPHENONE-S- SULFONIC ACID Inventor: Abraham J. Doner, deceased, late of North Miami Beach, Fla. by Cyril Doner, executor Assignee: Miles Laboratories, Inc., Eikhart, Ind.
Filed: Jan. 22, 1971 Appl. No.: 108,961
Related US. Application Data Continuation-in-part of Ser. No. 698,679, Dec. 18, 1967, abandoned.
US. Cl ..424/60, 424/47, 424/59,
424/80, 424/171, 424/184 Int. Cl. ..A61| 23/00 Field of Search ..424/59, 60, 331
Sagarin Cosmetic Science and Technology 195 7, p. 767. Lester, Handbook of Cosmetic Materials, 1954, p. 329
Primary Examiner-Albert T. Meyers Assistant ExaminerDale R. Ore Attorney-Hill, Sherman, Meroni, Gross & Simpson [57] ABSTRACT An active sunscreen ingredient comprised of 2-hydroxy-4- methoxy-benzophenone-S-suifonic acid, neutralized with triethanoiamine, and formulated with various compatible vehicles to produce efiective sunscreens for human use.
7 Claims, No Drawings SUNSCREEN FORMULATION CONTAINING TRIETHANOLAMINE NEUTRALIZED 2-HYDROXY-4- METHOXY-BENZOPHENONE-S-SULFONIC ACID CROSS-REFERENCE TO RELATED APPLICATIONS This is a continuation-in-part application of application Ser. No. 698,679 filed Dec. 18, 1967, now abandoned. Attention is also directed to prior application Ser. No. 358,616 filed Apr. 8, 1964, now abandoned.
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to ultraviolet absorbers and more particularly to sunscreen formulations for protection of human skin from solar radiation.
2. Prior Art Many sun tanning formulations for human skin are known, however, these do not effectively screen solar radiation from the skin. Chronic exposure to sunlight, even with such sun tanning formulations, has a deleterious effect on at least certain humans. For example, chronic exposure to sunlight .ap pears to significantly influence aging of human skin and/or produce skin cancer. Additionally, sunlight appears to precipitate or at least aggravate lupus erythematosus and con centrate skin lesions of pellagra and porphyria to the exposed skin areas. Also, a significant number of commonly used drugs produce photosensitivity in certain humans, which often result in polymorphic light sensitive eruptions. Among the more commonly used agent which produce sensitivity are the sulfonamides, tranquilizers of the phenothiazine type, the sulfonylurea oral antidiabetic agents and the antihypertensive diuretic agents.
The most common observation of the deleterious effect of exposure to sunlight is severe sunburn. However, a much less observed but just as common an effect of a single moderately severe sunburn is the abnormal characteristics of the blood vessels of a subject who has been exposed and which abnormalities remain present for a period of time ranging from 4 to 15 months. At present, no truly effective sunscreen agents are known that are compatible with human skin, and it will be appreciated that sun tanning agents are entirely different since they do not effectively absorb ultraviolet light. While certain benzophenone derivatives are utilized as sunscreen agents in protecting natural and man-made materials, such as textile goods, dyes and coloring agents, various resins, coating and film materials, and miscellaneous chemical compositions against the action of sunlight, these benzophenones are unsuitable for human skin for a number of reasons, including that they are highly irritating and do not lend themselves to acceptable formulations for human use.
Accordingly, it is an object of the invention to provide an effective sunscreen formulation for human skin that overcomes the aforesaid and additional disadvantages of heretofore available materials and to provide an adequate and safe protection for human skin from the effects of sunlight.
Other objects, features and advantages of the invention will become apparent to those skilled in the art from the teachings of the principles of the invention in connection with the disclosure of a preferred embodiment thereof in the specification and claims.
SUMMARY OF THE INVENTION The invention provides a sunscreen formulation containing an active ingredient for the protection of human skin from solar radiation comprised of a triethanolamine neutralized 2- hydroxy-4-methoxy benzophenone-S-sulfonic acid, in a compatible vehicle, which may include an emulsifier, such a glycerol monostearate, a wax, such as beeswax, water, an alcoho], such as denatured or cetyl alcohol, thickening agents, preservative agents, perfumes, etc. The amount of active ingredient within the formulation ranges in amounts from about 0.1 percent to about 30 percent.
DESCRIPTION OF THE PREFERRED EMBODIMENTS The invention provides a sunscreen agent that prevents and/or substantially minimizes the photochemical degradation and other adverse effects caused by exposure of human skin to sunlight through the absorption of ultraviolet wave lengths. The sunscreen agents of the invention absorb or screen radiation wave lengths responsible for erythema on human skin, minimizes the aging effects of solar radiation on humans and inhibits freckling or irregular pigmentation from such radiation. The sunscreen agents of the invention are readily incorporated into various types of vehicles for cosmetic materials, such as make-up bases, face powders, after-shave lotions, etc. for use by individuals who freckle, are afflicted with chloasma, or prefer their natural color, as well as by others. The sunscreen agents of the invention also tend to decrease sunlight accelerated aging and sunlight induced carcinogenesis on exposed human skin which has been coated with a formulation of said agents.
The sunscreen agents of the invention comprise Z-hydroxy- 4-methoxy-benzophenone-5-sulfonic acid neutralized with a neutralization agent having properties of triethanolamine and are formulated into any desired carrier, vehicle, emulsion, cream, lotion, ointment, solution, suspension, gel, aerosol or in any other form suitable for human usage. In its most preferred form, the active sunscreen agent of the invention is 2-hydroxy-4-methoxy-benzophenone-5sulfonic acid neutralized with triethanolamine. The amount of active sunscreen agent of the invention in a given formulation ranges from about 0. 1 percent to about 30 percent or more as desired.
The emulsions, gels, vehicles, etc. utilized in preparing sunscreen formulations containing the active sunscreening agents of the invention contain any one or combinations of; cetyl alcohol, stearyl alcohol, stearic or lauric acids and all other fatty acids and alcohols generally used in cosmetic and like materials emulsions or other formulations intended for human use; various waxes such as beeswax, microcrystalline wax, spermaceti, etc., and all other waxes generally used in cosmetic and like material emulsions or other formulations intended for human use; various petroleum materials, such as petrolatum, liquid petrolatum, mineral oil, silicone oil, etc. and all other oils, fats, and the like materials generally used in cosmetic and like material emulsions or other formulations intended for human use; fatty acid esters, such as isopropyl myristate and similar esters of fatty acids having a composition generally ranging from about C to about C various silicone derivatives, polyvinyl pyrrolidone methyl or propyl paraben, C to C glycols, various stearates, and other materials whether similar or otherwise that are generally used or considered suitable for use in cosmetic and like material emulsions or other formulations intended for human use.
Additionally, the vehicle materials, emulsifiers, combination of emulsifiers, and other like material compatible with the active sunscreen ingredients or agents of the invention are also selected from various anionic surfactants, including amine soaps of fatty acids such as characterized by triethanolamine stearate; cationic surfactants, such as characterized by monoethanol ammonium fluoride; amphoteric surfactants such as characterized by N-fatty B-amino-propionate (RNI-I CH -CH COOH); and nonionic surfactants such as characterized by sorbitan derivatives of C to C fatty acids, polyoxyethylene sorbitan derivatives of C to C fatty acids, polyoxyethylene esters of C to C fatty acids, glyceryl stearates, fatty acid polyisopropylene complexes; and ethylenes oxide fatty alcohol lanolin complexes. Other compatible materials, vehicles, carriers, gels and like materials include perfumes, clays, preservative agents, etc. and are all utilizable with the active sunscreen agents of the invention in formulating suitable gels, emulsions, either of the water-in-oil type or the oil-in-water type, aerosols, etc. or other forms suitable for application to humans.
In order to illustrate the invention and compare it with known sun-protective agents, comparative evaluations were made of twenty-four agents by applying such agents to the shaved abdomens of albino rabbits and determining the Minimal Erythema Dose (M.E.D.). An embodiment of the invention within this comparative group was triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid. The M.E.D. for an unprotected rabbit (i.e. one without having any protective agent on it) was found to be 25-30 seconds. Of the known protective agents, the longest or best protection provided was 3 to 5 minutes and only four of the preparations studied gave results that were this satisfactory. A 5 percent concentration of PABA (para-amino-benzoic-acid) and a 5 percent concentration of triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid in a compatible vehicle, each provided protection for about 20 to 25 minutes. By doubling the concentration of these two agents in similar formulations and applying them to rabbits, the M.E.D. was increased in both instances to approximately 100 minutes. However, PABA and its esters tended to produce epidermal sensitization and to produce cross-sensitization reaction with benzocaine, sulfonamides, and the aniline dyes.
The active sunscreen agents of the invention generally comprise suitably neutralized 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid, and similar benzophenone derivatives having the formula:
i O @OCH3 wherein A is selected from a neutralizing agent having properties characterized by triethanolamine. The active sunscreen agents of the invention are utilized in a variety of formulations and are present therein in amounts ranging from about 0.1 percent to about 30 percent by weight.
In order to further illustrate, and not limit the sunscreen agents of the invention in various formulations, bases, carriers, emulsifiers and other compatible vehicles, the following examples are set forth.
A 2-hydroxy-4-methoxy benzophenone-S-sulfonic acid is available from Antara Chemical, New York, New York under the registered tradename UVINUL MS40 and U- VINUL-40-20 percent Aqueous Solution. UVINUL MS-40" is a free flowing powder at 25 C., light-cream in color and has a molecular weigh of 309 and a pH 2 for a l percent aqueous solution, with a solubility of about 5 g/lOO mls of water at 25 C. after 15 minutes of agitation. Of course U- VINUL MS-40-20% Aqueous Solution is the same material in an aqueous solution at the concentration indicated. In preparing sunscreen formulations utilizing powdered U- VINUL MS-40, the powder is first dissolved in water and then combined with a suitable neutralizing agent and a particular vehicle.
EXAMPLE I A typical embodiment of an oil-in-water emulsion formulation utilizing UVINUL MS-40-20% Aqueous Solution, (referred to as Benzophenone Derivative) in its neutralized form, an the active ingredient is as follows, with all parts being by weight unless otherwise noted.
Active Ingredient Amounts Benzophenone Derivative Triethanolamine (U.S.P.) Q.S." Emulsion Vehicle ARLACEL 165 (Glyceryl Monostearate) 5% Cetyl Alcohol 2% Isopropyl Palmitate 2% Dimethyl Silicone Oil 3% Light Liquid Petrolatum 2% Polyvinyl Pyrrolidone 0.5%
"Sorbo 70%" Distilled Water "ARLACEL is a tradename for a glyceryl monostearate containing emulsifier available from Atlas Chemical Industries, Inc., of Wilmington, Delaware and Sorbo 70% is a tradename for a sorbitol containing emollient having 70 percent solids also available from Atlas Chemical Industries, Inc. An alternative emulsifier usable in place of "ARLACEL 165" is Prornulgen," a tradename for an emulsifier available from Robinson Wagner Company, Inc., of Mamaroneck, New York.
The above embodiment of a particular formulation can be varied by adjusting the amount of active ingredient so as to vary between about O.l percent to about 30 percent and by adjusting and/or omitting certain ingredients of the vehicle. For example, the amount of glycerol monostearate can vary between about 3 percent to 5 percent, the silicone oil, i.e. dimethyl silicone oil, and/or the petrolatum can be replaced by mineral oil and the amount varied between about 1 percent to 15 percent, the amount of sorbitol varied between about 3 percent to 30 percent or partially replaced by a glycol, the amounts of isopropyl palmitate, and polyvinyl pyrrolidone may also be varied and/or replaced with other comparable material and even omitted as exemplified in further embodiments set forth hereinafter. Of course, minor amounts perfumes and/or preservative agents are added as desired.
It will be understood that the invention is not limited to the specific proprietary items set forth in the examples but includes all emulsifiers, emollients, carriers, vehicles, preservatives, perfumes and other materials generally found in cosmetic materials, sun protective formulations, etc., suitable for use on human skin.
The formulation of the above embodiment of an oil-inwater emulsion is carried out by placing the appropriate amounts of ARLACEL 165, cetyl alcohol, dimethyl silicone oil and light liquid petroletum in a suitable steam-jacketed kettle or the like and subjecting the mixture to slow agitation and heating conditions to about 70 C. so as to form a first solution. The remaining ingredients of the emulsion vehicle, i.e. all of the remainder ingredients except the active ingredient, are placed in another suitable container and slowly agitated and heated up to about 75 C. to form a second solution. The two solutions are then combined with continuous and vigorous agitation by adding the second solution to the first solution. Thereafter the sulfonated 2-hydroxy-4-methoxybenzophenone derivative is neutralized with a sufficient amount of an amine having properties characterized by triethanolamine and added to the combined solutions at about 35 C. with agitation sufficient to achieve a generally homogeneous or uniform mixture. Perfumes or preservative agents such as methyl and/or propyl paraben or the like can readily be included in the formulation in an appropriate amount, if desired.
EXAMPLE II A typical embodiment of a water-in-oil formulation utilizing 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in its neutralized form as the active ingredient is as follows, again all parts being by weight unless otherwise noted.
Active Ingredient Amounts Benzophenone Derivative 3% to Triethanolamine (U.S.P.) 0.5.
Emulsion Vehicle ARLACEL I86" (Monoand di- Glycerides of fat forming fatty acids) 3% SORBO" (70% aqueous solution of d-sorbitol) 27% Ceresin Wax 1% Beeswax 1% Mineral Oil 1 1% Water to 100% ARLACEL 186" and SORBO are tradenames of an emulsifier and an emollient respectively, available from the Atlas Chemical Industries, Inc. referred to earlier.
The formulation of the above embodiments is carried out by preparing an intermediate gel comprised of adding a small amount of SORBO and ARLACEL 186 and subjecting the mixture of mechanical agitation to form a relatively thick slurry. Thereafter, the remainder of SORBO ingredient is added with continuous agitation and then the benzophenone derivative, in its neutralized form, the waxes and the mineral oil are added to the intermediate gel and slowly agitated and heat up to about 70 C. The water is then heated to about 72 C. and added to the gel mixture with continuous agitation. The agitation is continued until the resultant formulation cools to room temperature. In order to provide maximum smoothness and stability, the formulation is subjected to homogenization or milling procedures.
EXAMPLE III A typical embodiment of a liquid solvent formulation utilizing 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in its neutralized form as the active ingredient is as follows, with all parts being by weight.
Active Ingredient Amounts Benzophenone Derivative Neutralizing Agent Q.S." Solvent Vehicle Specially Denatured Alcohol (SBA-40) 20% Alcohol Soluble Silicone Oil 3% Purified Water to 100% A denatured ethyl alcohol approved by the US. Government for use in various cosmetics and like formulations.
The formulation of the above embodiment is carried out by combining the active ingredient with the solvent vehicle under vigorous agitation and gentle heat conditions for a period of time sufficient to produce a relatively clear solution. Perfumes or the like are also added as desired.
EXAMPLE IV A typical embodiment of a gel (clear or opaque) formulation utilizing 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in its neutralized form as the active ingredient is as follows, with all parts being by weight.
Active Ingredient Amounts Benzophenone Derivative 10% Triethanolamine (U.S.P.) Q.S." Gel Vehicle Specially Denatured Alcohol (SDA-40)" 30% Alcohol Soluble Silicone 3% Carbopol 940" (Synthetic I-lydrophilic Colloids in white free flowing powder form) 0.5% Water to 100% "lbid.
Carbopol 940 is a tradename for an emulsifier material comprised of a vinyl polymer with active carboxyl groups available from B. F. Goodrich Company (The Merck Index, 8th Edision, 1968, Page 201 The formulation of the above gel embodiment is carried out by combining the gel vehicle with the benzophenone derivative under agitation and heat conditions sufficient to produce a clear gel solution. Thereafter the triethanolamine is slowly stirred into the solution until a gel forms. The formed gel is suitable for use on human skins.
The benzophenone derivative is carried into an appropriate vehicle by dissolving or suspending it in water, alcohol, glycerine, propylene glycol or any other suitable solvent or combination of solvents generally recognized as safe or compatible to human skin. Further suitable suspension agents, such as organic clays, pectin, synthetic resins, etc. are also utilizable in appropriate proportions in the formulations of the invention, additionally, tragacanth, agar-agar or similarly characterized thickening agents are also suitable for use in the formulations of the invention.
In order to further illustrate the sunscreen agents and formulations of the invention and to illustrate their relative effectiveness on humans and compared them with known sun protective agents, a number of known sun protective agents and the sunscreen formulation essentially identical to that of Example I having various concentrations of active sunscreen ingredients were applied to male and female volunteers. An ultraviolet lamp, Burdick Model QA-450-N, producing ultraviolet radiation ranging from 2,400 to 3,300 angstroms, with the majority of the radiation being between 2,800 to 3,200 angstroms was used. (Sunburn to human skin is generally produced by the electromagnetic spectrum located between 2,900 and 3,170 angstroms, with maximal effects at about 2,970 angstroms.) The M.E.D. (Minimal Erythema Dose) for each volunteer was established on the abdomen and the back with the ultraviolet lamp at a distance of thirty inches. The various formulations studied were applied by hand and rubbed into a skin area in the same manner as an individual does before being exposed to the sun. No excess material was utilized and the amount varied, but was generally only sufiicient to permit the volunteers to feel comfortable. In each instance, the applied formulations were allowed to dry before exposure to the ultraviolet and the results were averaged.
Average Protection Para-amino-benzoic acid 15% in Aquaphor Red Veterinary Petrolatum 30 but less than 40 40 but less than 60 2-ethoxy-ethyl-p-methoxy-cinnamate less than 5 Yellow Vasoline (U.S.P.) 30 but less than 40 Digalloyl-trioleate less than 5 10% neutralized benzophenone derivative of the invention in a lotion base 5% neutralized benzophenone derivative of the invention in a location base 2% neutralized benzophenone derivative of the invention in a lotion base 5 10% neutralized benzophenone derivative 10 but less than 20 of the invention in an alcohol vehicle 40 The emulsion vehicle of Example I, without the active ingredient less than 5 Non-neutralized benzophenone derivative results inconelusive The non-neutralized benzophenone derivative in a lotion base was considered to be irritating and unacceptable for human use.
In summation, the invention provides active sunscreen agents or ingredients compatible with a wide variety of vehicles or carriers in sunscreen formulations wherein the active ingredient is present in amounts ranging from about 0.1 percent to about 30 percent. The preferred active ingredient of the invention is 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid neutralized with triethanolamine, although other suitably neutralized 2-hydroxy-4-methoxy-benzophenone-5- sulfonic acid derivatives are also utilizable.
It is to be understood that the foregoing relates only to the preferred embodiments of the invention and changes, modifications and variations can be effected without departing from the scope or spirit of the novel concepts of the invention.
I claim:
1. A sunscreen formulation in the form of an emulsified 10- tion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid in amounts ranging from 0.1 percent to 30 percent of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 3 percent to 5 percent glycerol monostearate, 1 percent to 3 percent cetyl alcohol, 1 percent to 3 percent isopropyl palmitate, 1 percent to 15 percent dimethyl silicone oil, percent to 3 percent light liquid petrolatum, 0.1 percent to 1 percent polyvinyl pyrrolidone, 3 percent to 30 percent sorbitol and up to 100 percent water.
2. A sunscreen formulation as defined in claim 11 wherein the compatible vehicle includes a preservative amount of preservative material selected from the group consisting of methyl paraben, propyl paraben and mixtures thereof.
3. A sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid in amounts ranging; from 0.l percent to 30 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 3 percent to 5 percent glycerol monostearate, 2 percent cetyl alcohol, 2 percent isopropyl palrnitate, 3 percent dimethyl silicone oil, 2 percent light liquid petrolatum, 0.5 percent polyvinyl pyrrolidone, 7 percent sorbitol and up to 100 percent water.
4. A sunscreen formulation in the form of an emulsified 10- tion suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4rnethoxy-benzophenone-S-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 5 percent glycerol monostearate, 2 percent cetyl alcohol, 2 percent isopropyl palmitate, 3 percent dimethyl silicone oil, 2 percent light liquid petrolatum, 0.5
percent polyvinyl pyrrolidone, 7 percent sorbitol and up to percent water.
5. A sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-S-sulfonic acid in amounts ranging from about 3 percent to 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanol-amine, and a compatible vehicle comprising a mixture of, by weight, 3 percent glycerol monoand di-stearate, 19 percent sorbitol, 1 percent ceresin wax, 1 percent beeswax, ll percent mineral oil and up to 100 percent water.
6. A sunscreen formulation in the form of a liquid suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4-methoxy-benzophenone-S-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 20 percent denatured alcohol, 3 percent dimethyl silicone oil and up to 100 percent water.
7. A sunscreen formulation in the form of a liquid suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4-methoxy-benzophenonc-5-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 30 percent denatured alcohol, 3 percent dirnethyl silicone oil, 0.5 percent glycerol monostearate and up to 100 percent water.
I! 4 I I III UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTIQN 3, 670, 074 Dated June 13, 1972 Patent No.
lnvvnrorhz) Aln'uhzun J. Holler It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
Column 6, line 42, change "location" to --1otion-,
Column 7, line 6, change "11" to --l--.
Signed and sealed this 17th day of September 1974 (SEAL) Attest:
MCCOY M. GIBSON JR. C. MARSHALL DANN Attesting Officer Commissioner of Patents ORM PO-1OSO (10-69) USCOMM-DC 60376-P69 u.s, eovsnmaam PRINTlNG orncs; I969 o-ass-aaa.
Claims (6)
- 2. A sunscreen formulation as defined in claim 11 wherein the compatible vehicle includes a preservative amount of preservative material selected from the group consisting of methyl paraben, propyl paraben and mixtures thereof.
- 3. A sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid in amounts ranging from 0.1 percent to 30 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 3 percent to 5 percent glycerol monostearate, 2 percent cetyl alcohol, 2 percent isopropyl palmitate, 3 percent dimethyl silicone oil, 2 percent light liquid petrolatum, 0.5 percent polyvinyl pyrrolidone, 7 percent sorbitol and up to 100 percent water.
- 4. A sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4methoxy-benzophenone-5-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 5 percent glycerol monostearate, 2 percent cetyl alcohol, 2 percent isopropyl palmitate, 3 percent dimethyl silicone oil, 2 percent light liquid petrolatum, 0.5 percent polyvinyl pyrrolidone, 7 percent sorbitol and up to 100 percent water.
- 5. A sunscreen formulation in the form of an emulsified lotion suitable for application to human skin comprising; an active ingredient consisting essentially of 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid in amounts ranging from about 3 percent to 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanol-amine, and a compatible vehicle comprising a mixture of, by weight, 3 percent glycerol mono- and di-stearate, 19 percent sorbitol, 1 percent ceresin wax, 1 percent beeswax, 11 percent mineral oil and up to 100 percent water.
- 6. A sunscreen formulation in the form of a liquid suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 20 percent denatured alcohol, 3 percent dimethyl silicone oil and up to 100 percent water.
- 7. A sunscreen formulation in the form of a liquid suitable for application to human skin comprising; an active ingredient of 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid in an amount of 10 percent by weight of said formulation, said sulfonic acid being neutralized with triethanolamine, and a compatible vehicle comprising a mixture of, by weight, 30 percent denatured alcohol, 3 percent dimethyl silicone oil, 0.5 percent glycerol monostearate and up to 100 percent water.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10896171A | 1971-01-22 | 1971-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3670074A true US3670074A (en) | 1972-06-13 |
Family
ID=22325063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US108961A Expired - Lifetime US3670074A (en) | 1971-01-22 | 1971-01-22 | Sunscreen formulation containing triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid |
Country Status (1)
Country | Link |
---|---|
US (1) | US3670074A (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4250108A (en) * | 1973-02-19 | 1981-02-10 | L'oreal | Process for preparing (2-oxo-3-bornylidene/methyl)-benzene sulfonic acids |
FR2493838A1 (en) * | 1980-11-12 | 1982-05-14 | Riedel De Haen Ag | Neutralising aq. 2-hydroxy-4-methoxy- benzophenone-5-sulphonic acid - with amine forming no ppte., soln. used as impregnant for UV light-sensitive substrate |
US4331651A (en) * | 1979-01-23 | 1982-05-25 | Hoechst Aktiengesellschaft | Depot body on the basis of silicone rubber and process for the preparation thereof |
US4457911A (en) * | 1981-01-28 | 1984-07-03 | Van Dyk & Company Inc. | Dialkyl malonates as organic sunscreen adjuvants |
US4699779A (en) * | 1986-02-18 | 1987-10-13 | Victor Palinczar | Waterproof sunscreen compositions |
US4710371A (en) * | 1986-02-19 | 1987-12-01 | Victor Palinczar | Waterproof sunscreen compositions |
EP0275719A3 (en) * | 1986-12-30 | 1988-08-10 | Richardson-Vicks, Inc. | Ultraviolet absorbing compounds and formulations including same |
US4810489A (en) * | 1986-12-04 | 1989-03-07 | Bristol-Myers Company | High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors |
US4840788A (en) * | 1986-07-15 | 1989-06-20 | Ici Americas Inc. | Nonalcoholic sunscreen gel |
FR2627085A1 (en) * | 1988-02-11 | 1989-08-18 | Oreal | USE OF 2-HYDROXY-4-METHOXYBENZOPHENONE-5-SULFONIC ACID OR ITS SALTS FOR HAIR PROTECTION AGAINST ATMOSPHERIC AGGRESSIONS, ESPECIALLY AGAINST LIGHT, AND HAIR PROTECTION METHOD USING THE SAME |
US4897259A (en) * | 1986-12-04 | 1990-01-30 | Bristol-Myers Company | High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors |
US5004598A (en) * | 1986-11-10 | 1991-04-02 | The B. F. Goodrich Company | Stable and quick-breaking topical skin compositions |
FR2680685A1 (en) * | 1991-08-30 | 1993-03-05 | Oreal | SOLAR COSMETIC GEL CONTAINING SUSPENSION HYDRATED SPHEROUIDS OF A HYDROPHILIC LIPID SUBSTANCE AND, IN SOLUTION IN THE AQUEOUS PHASE, A SULPHONIC UV FILTER. |
US5240695A (en) * | 1988-02-11 | 1993-08-31 | L'oreal | Use of 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or its salts for protecting the hair against environmental attacking agents, and especially against light and process for protecting the hair using the compound |
DE4322759C1 (en) * | 1993-07-08 | 1994-09-01 | Kao Corp Gmbh | Hair-treatment composition |
FR2706766A1 (en) * | 1993-06-21 | 1994-12-30 | Oreal | |
EP0821940A1 (en) * | 1996-07-31 | 1998-02-04 | 3V SIGMA S.p.A | Sun screening preparations comprising triazine derivatives |
WO2019032059A1 (en) | 2017-08-11 | 2019-02-14 | Dokuz Eylül Üni̇versi̇tesi̇ Rektörlüğü | A phosphorus based sunscreen converting ultraviolet radiation to red wavelengths |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2614940A (en) * | 1948-12-31 | 1952-10-21 | Gen Aniline & Film Corp | Ultraviolet light absorbing film |
US2664383A (en) * | 1950-11-13 | 1953-12-29 | Colgate Palmolive Peet Co | Color-stable toilet waters and perfumes |
US2876210A (en) * | 1954-02-10 | 1959-03-03 | Gen Aniline & Film Corp | 2,2'-dihydroxy-4, 4'-substituted benzophenones as ultraviolet absorbents for gr-a rubber |
US3068151A (en) * | 1958-05-19 | 1962-12-11 | Procter & Gamble | Hair control composition |
US3123647A (en) * | 1964-03-03 | Certificate of correction | ||
US3479428A (en) * | 1963-07-12 | 1969-11-18 | Boots Pure Drug Co Ltd | Sunscreen composition and method of using the same |
-
1971
- 1971-01-22 US US108961A patent/US3670074A/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123647A (en) * | 1964-03-03 | Certificate of correction | ||
US2614940A (en) * | 1948-12-31 | 1952-10-21 | Gen Aniline & Film Corp | Ultraviolet light absorbing film |
US2664383A (en) * | 1950-11-13 | 1953-12-29 | Colgate Palmolive Peet Co | Color-stable toilet waters and perfumes |
US2876210A (en) * | 1954-02-10 | 1959-03-03 | Gen Aniline & Film Corp | 2,2'-dihydroxy-4, 4'-substituted benzophenones as ultraviolet absorbents for gr-a rubber |
US3068151A (en) * | 1958-05-19 | 1962-12-11 | Procter & Gamble | Hair control composition |
US3479428A (en) * | 1963-07-12 | 1969-11-18 | Boots Pure Drug Co Ltd | Sunscreen composition and method of using the same |
Non-Patent Citations (2)
Title |
---|
Lester, Handbook of Cosmetic Materials, 1954, pp. 320. * |
Sagarin Cosmetic Science and Technology 1957, pp. 767. * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4250108A (en) * | 1973-02-19 | 1981-02-10 | L'oreal | Process for preparing (2-oxo-3-bornylidene/methyl)-benzene sulfonic acids |
US4331651A (en) * | 1979-01-23 | 1982-05-25 | Hoechst Aktiengesellschaft | Depot body on the basis of silicone rubber and process for the preparation thereof |
FR2493838A1 (en) * | 1980-11-12 | 1982-05-14 | Riedel De Haen Ag | Neutralising aq. 2-hydroxy-4-methoxy- benzophenone-5-sulphonic acid - with amine forming no ppte., soln. used as impregnant for UV light-sensitive substrate |
DE3042541A1 (en) * | 1980-11-12 | 1982-05-19 | Riedel-De Haen Ag, 3016 Seelze | AQUEOUS SOLUTION OF 2-HYDROXY-4-METHOXYBENZOPHENONE-5-SULFONIC ACID, METHOD FOR THE PRODUCTION AND USE THEREOF |
US4457911A (en) * | 1981-01-28 | 1984-07-03 | Van Dyk & Company Inc. | Dialkyl malonates as organic sunscreen adjuvants |
US4699779A (en) * | 1986-02-18 | 1987-10-13 | Victor Palinczar | Waterproof sunscreen compositions |
US4710371A (en) * | 1986-02-19 | 1987-12-01 | Victor Palinczar | Waterproof sunscreen compositions |
US4840788A (en) * | 1986-07-15 | 1989-06-20 | Ici Americas Inc. | Nonalcoholic sunscreen gel |
US5004598A (en) * | 1986-11-10 | 1991-04-02 | The B. F. Goodrich Company | Stable and quick-breaking topical skin compositions |
US4897259A (en) * | 1986-12-04 | 1990-01-30 | Bristol-Myers Company | High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors |
US4810489A (en) * | 1986-12-04 | 1989-03-07 | Bristol-Myers Company | High oil phase pharmaceutical vehicles and sunscreen compositions having waterproof sun protection factors |
EP0275719A3 (en) * | 1986-12-30 | 1988-08-10 | Richardson-Vicks, Inc. | Ultraviolet absorbing compounds and formulations including same |
US5240695A (en) * | 1988-02-11 | 1993-08-31 | L'oreal | Use of 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or its salts for protecting the hair against environmental attacking agents, and especially against light and process for protecting the hair using the compound |
GB2215602A (en) * | 1988-02-11 | 1989-09-27 | Oreal | A process for protecting the hair using 2-hydroxy-4-methoxybenzophenone-5-sulphonic acid or a salt thereof |
GB2215602B (en) * | 1988-02-11 | 1991-10-02 | Oreal | A process for protecting the hair using 2-hydroxy-4-methoxybenzophenone-5- sulphonic acid or a salt thereof |
BE1003099A5 (en) * | 1988-02-11 | 1991-11-26 | Oreal | USE OF 2-HYDROXY-4-METHOXYBENZOPHENONE-5-SULFONIC ACID OR ITS SALTS FOR THE PROTECTION OF HAIR AGAINST ATMOSPHERIC AGGRESSIONS, AND PARTICULARLY AGAINST LIGHT, AND METHOD FOR PROTECTING HAIR USING THIS COMPOUND. |
FR2627085A1 (en) * | 1988-02-11 | 1989-08-18 | Oreal | USE OF 2-HYDROXY-4-METHOXYBENZOPHENONE-5-SULFONIC ACID OR ITS SALTS FOR HAIR PROTECTION AGAINST ATMOSPHERIC AGGRESSIONS, ESPECIALLY AGAINST LIGHT, AND HAIR PROTECTION METHOD USING THE SAME |
FR2680685A1 (en) * | 1991-08-30 | 1993-03-05 | Oreal | SOLAR COSMETIC GEL CONTAINING SUSPENSION HYDRATED SPHEROUIDS OF A HYDROPHILIC LIPID SUBSTANCE AND, IN SOLUTION IN THE AQUEOUS PHASE, A SULPHONIC UV FILTER. |
EP0531192A1 (en) * | 1991-08-30 | 1993-03-10 | L'oreal | Cosmetic sunblock gels containing in suspension hydrated spheroids of hydrophilic lipidic substance and in solution in this aqueous gel an UV-filter of the sulfonic type |
US5635163A (en) * | 1993-06-21 | 1997-06-03 | L'oreal | Screening cosmetic compositions containing a hydrophilic agent comprising at least one sulphonic acid radical |
FR2706766A1 (en) * | 1993-06-21 | 1994-12-30 | Oreal | |
WO1995000111A1 (en) * | 1993-06-21 | 1995-01-05 | L'oreal | Cosmetic filtering compositions containing a hydrophilic agent with at least one sulphonic acid radical |
JP2865425B2 (en) | 1993-06-21 | 1999-03-08 | ロレアル | Shielding cosmetic composition containing hydrophilic agent having at least one sulfonic acid group |
DE4322759C1 (en) * | 1993-07-08 | 1994-09-01 | Kao Corp Gmbh | Hair-treatment composition |
EP0821940A1 (en) * | 1996-07-31 | 1998-02-04 | 3V SIGMA S.p.A | Sun screening preparations comprising triazine derivatives |
WO2019032059A1 (en) | 2017-08-11 | 2019-02-14 | Dokuz Eylül Üni̇versi̇tesi̇ Rektörlüğü | A phosphorus based sunscreen converting ultraviolet radiation to red wavelengths |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3670074A (en) | Sunscreen formulation containing triethanolamine neutralized 2-hydroxy-4-methoxy-benzophenone-5-sulfonic acid | |
JP2812690B2 (en) | Photoprotective composition containing tocopherol sorbate | |
JP2885808B2 (en) | Photoprotective composition comprising tocopherol sorbate and anti-inflammatory agent | |
AU689100B2 (en) | Sunscreens containing plant extracts | |
US4996239A (en) | Water resistant cream conditioner | |
CA1078738A (en) | Artificial skin darkening compositions | |
US5384115A (en) | Photoprotection compositions comprising a radical scavenging compound and an anti-inflammatory agent | |
EP0313302B1 (en) | Photoprotection compositions comprising sorbohydroxamic acid | |
JP3655305B2 (en) | Self-tanning cosmetic composition and method of using the same | |
EP0418443B1 (en) | Waterproof sunscreen | |
US4863725A (en) | Novel clear oil-free moisturizer composition | |
GB1573957A (en) | Compositions suitable for tanning the skin based on pyridine derivatives | |
US5208011A (en) | Ultraviolet resistant sunscreen compositions | |
JPH01265017A (en) | Light protective composition containing sorbohydroxamic acid and anti-inflammory drug | |
JPH01265018A (en) | Light protective composition containing chelate agent | |
JPS6251608A (en) | Improved moisture rising lotion | |
US5039513A (en) | Photoprotection compositions and methods comprising sorbohydroxamic acid | |
US20040126339A1 (en) | Sunscreen composition and methods for manufacturing and using a sunscreen composition | |
US5098717A (en) | Method of treatment for pruritus | |
WO1985004101A1 (en) | Skin treatment compositions | |
Peluso et al. | Photocontact dermatitis due to Eusolex 4360. | |
CA2156930C (en) | Sunscreens containing plant extracts | |
JPH03287513A (en) | Skin external preparations | |
Howard | Sunburn preparations | |
JPS61204110A (en) | Cosmetic having improved light resistance |